scispace - formally typeset
Y

Yeon-Kyung Choi

Researcher at Kyungpook National University

Publications -  33
Citations -  1199

Yeon-Kyung Choi is an academic researcher from Kyungpook National University. The author has contributed to research in topics: Medicine & Glutamine. The author has an hindex of 14, co-authored 24 publications receiving 851 citations. Previous affiliations of Yeon-Kyung Choi include Kyungpook National University Hospital.

Papers
More filters
Journal ArticleDOI

Serum irisin levels in new-onset type 2 diabetes

Yeon-Kyung Choi, +8 more
- 01 Apr 2013 - 
TL;DR: It is found that serum irisin levels were decreased in T1D patients and inversely associated with newly diagnosed T2D, suggesting that irisin may play a crucial role in glucose intolerance and T2 D.
Journal ArticleDOI

Targeting Glutamine Metabolism for Cancer Treatment

Yeon-Kyung Choi, +1 more
- 01 Jan 2018 - 
TL;DR: An overview of the role of glutamine metabolism in cancer cell survival and growth is provided and the potential therapeutic approaches of targeting glutamines metabolism for the treatment of numerous types of cancer are summarized.
Journal ArticleDOI

Inhibition of Glutamine Utilization Synergizes with Immune Checkpoint Inhibitor to Promote Antitumor Immunity

Jun-Kyu Byun, +14 more
- 19 Nov 2020 - 
TL;DR: It is reported that limiting glutamine metabolism in cancer cells bolsters the effectiveness of anti-programmed death ligand-1 (PD-L1) antibody and suggested that co-targeting of glutamines metabolism and PD- L1 represents a promising therapeutic approach.
Journal ArticleDOI

Sitagliptin attenuates methionine/choline-deficient diet-induced steatohepatitis

Yun-A Jung, +9 more
- 01 Jul 2014 - 
TL;DR: Sitagliptin attenuated MCD diet-induced hepatic steatosis, inflammation, and fibrosis in mice through amelioration of mechanisms responsible for the development of NASH, including CD36 expression, NF-κB activation, ER stress, CYP2E1 expression, and lipid peroxidation.
Journal ArticleDOI

A Positive Feedback Loop between Sestrin2 and mTORC2 Is Required for the Survival of Glutamine-Depleted Lung Cancer Cells

Jun-Kyu Byun, +10 more
- 18 Jul 2017 - 
TL;DR: In this article, Sestrin2 and mTORC2 are upregulated in glutamine-depleted lung cancer cells, which is necessary for the survival of the cells.